Tygacil Drug Use Investigation (Tigecycline Evaluation Study For Safety And Effectiveness In Patient Infected With Multi-Drug Resistance.)
Phase of Trial: Phase IV
Latest Information Update: 13 Feb 2019
Price : $35 *
At a glance
- Drugs Tigecycline (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- Acronyms TIGER
- Sponsors Pfizer
- 09 Mar 2018 The primary endpoint has been amended to "Number of Participants with adverse events". Hence the trial focus has changed from TU to AR.
- 14 Jul 2017 Status changed from active, no longer recruiting to completed.
- 07 Apr 2017 Planned End Date changed from 8 May 2017 to 1 Jun 2017.